O'Connell Daniel's most recent trade in Acumen Pharmaceuticals Inc was a trade of 12,619 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Jan. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 21 Jan 2025 | 12,619 | 667,488 | - | 1.6 | 20,102 | Common Stock |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 338,000 | 338,000 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 225,400 | 680,107 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.84 per share. | 03 Jan 2025 | 47,778 | 454,707 | - | 1.8 | 87,873 | Common Stock |
| Acumen Pharmaceuticals Inc | O'Connell Daniel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 19 Jan 2024 | 15,200 | 502,485 | - | 3.5 | 52,753 | Common Stock |
| Acumen Pharmaceuticals Inc | O'Connell Daniel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 602,000 | 602,000 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 401,000 | 517,685 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 472,500 | 472,500 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 114,000 | 116,685 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 455,000 | 455,000 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 1,118 | 0 | - | - | Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.47 per share. | 30 Nov 2021 | 1,118 | 2,685 | - | 4.5 | 4,997 | Common Stock |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | 06 Jul 2021 | 123 | 0 | - | - | Series A Preferred Stock | ||
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | 06 Jul 2021 | 123 | 1,542 | - | - | Common Stock | ||
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | 06 Jul 2021 | 35 | 1,577 | - | 4.5 | 156 | Common Stock | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 35 | 0 | - | - | Warrant (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Daniel O'Connell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.00 per share. | 06 Jul 2021 | 10 | 1,567 | - | 16 | 160 | Common Stock |